Encompass Health revenue and financials
$122.63Change from previous close: −1.65%Absolute change: −$2.06
In the fiscal year ended December 2025, Encompass Health reported revenue of $5.94B (+10.46% year over year). Net income was $566.2M, a net margin of 9.5%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +10.46%
- 2025 vs 2024
- Net income growth
- +24.25%
- 2025 vs 2024
- Net margin
- 9.5%
- 2024: 8.5%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 5,935 | 5,373 | 4,801 | 4,349 | 4,015 |
| Cost of revenue | 3,370 | 3,140 | 2,818 | 2,595 | 2,312 |
| Gross profit | 2,565 | 2,233 | 1,983 | 1,753 | 1,703 |
| Selling, general and administrative | 301 | 272 | 264 | 209 | 229 |
| Operating income | 1,053 | 875 | 732 | 630 | 659 |
| EBIT | 1,053 | 875 | 732 | 630 | 659 |
| EBITDA | 1,381 | 1,175 | 1,006 | 874 | 879 |
| Interest expense | 123 | 137 | 144 | 176 | 164 |
| Pre-tax income | 953 | 750 | 607 | 451 | 505 |
| Income tax | 193 | 150 | 132 | 100 | 102 |
| Net income | 566 | 456 | 352 | 271 | 412 |
| Net income to common shareholders | 565 | 453 | 350 | 270 | 410 |
| Basic EPS | 5.62 | 4.53 | 3.51 | 2.72 | 4.15 |
| Diluted EPS | 5.54 | 4.46 | 3.47 | 2.70 | 4.11 |
| Average shares (basic) | 101 | 99.9 | 99.5 | 99.2 | 99.0 |
| Average shares (diluted) | 102 | 102 | 101 | 100 | 100 |
| Dividend per share | 0.72 | 0.64 | 0.60 | 0.86 | 1.12 |